Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (... Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need. We are currently focusing our development efforts on our immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), our majority-owned subsidiary. These programs include three distinctive complementary CpG-STAT3 inhibitors: Antisense ("DUET-101"); RNA silencing ("DUET-202"); and DNA-binding inhibitor ("DUET-301"). The Company may also seek to develop additional drug candidates and identify additional compelling technologies for potential acquisition, in-licensing and/or other similar transactions. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0003 | 0.0003 | 0.0003 | 4001 | 0.0003 | CS |
| 4 | 0 | 0 | 0.0003 | 0.0003 | 0.0002 | 6600 | 0.00029989 | CS |
| 12 | 0 | 0 | 0.0003 | 0.01 | 0.0002 | 17392 | 0.00031578 | CS |
| 26 | 0.000299 | 29900 | 1.0E-6 | 0.01 | 1.0E-6 | 12385 | 0.00030805 | CS |
| 52 | -0.0417 | -99.2857142857 | 0.042 | 0.0637 | 1.0E-6 | 9502 | 0.00546377 | CS |
| 156 | -0.0848 | -99.6474735605 | 0.0851 | 0.156 | 1.0E-6 | 24307 | 0.07277803 | CS |
| 260 | -0.0848 | -99.6474735605 | 0.0851 | 0.156 | 1.0E-6 | 24307 | 0.07277803 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
